The importance of embryonic stage-specific molecules in the regulation of cell interactions and cell sorting during development and differentiation has been postulated; however, experimental confirmation of this postulate is scarce. Several candidates for stage-specific molecules have been found by using antisera, raised by both syngeneic (1, 2) and xenogeneic (3) immunization with embryonal carcinoma cells (ECG) or by xenogeneic immunization (4) with mouse embryos. Indeed, inhibition of development of preimplantation mouse embryos by Fab fragments isolated from antisera to the murine teratocarcinoma cell F9 has recently been reported (5). However, such sera contain antibodies to multiple antigenic determinants, which precludes precise definition of embryo stage-specific antigens. In order to circumvent this difficulty and to study the stage-specific molecules in a methodical fashion, we are producing monoclonal antibodies (6) reactive with teratocarcinoma cells and embryos. Production and characterization of one such antibody is described here.
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MATERIALS AND METHODS
Preparation of Monoclonal Reagents. BALB/c mice were immunized by weekly intraperitoneal injection of 107 irradiated F9 cells. The mice were tail-bled 7 days after each injection, and sera were tested for reactivity on F9 cells. Three days after the seventh immunization, the spleen was removed from one mouse, which showed a high titer of antibody reactivity. Splenic lymphocytes were isolated and fused with the P3-X63-Ag8 mouse myeloma cell line as described (6) (7) (8) . Hybrid cell lines were isolated by growth of the fusion mixtures in Dulbecco's modification of Eagle's minimal essential medium containing 10% fetal bovine serum, 2 mM glutamine, and the HAT components (hypoxanthine/aminopterin/thymidine) (9) . Supernatants from Linbro wells containing growing colonies were tested for reactivity on F9 cells by an indirect antibody binding radioimmunoassay (RIA) . One positive colony was transferred to mass culture and cloned. Supernatants from clones were also tested in RIA and the positive clones were maintained in tissue culture. Supernatants were collected from dense cultures of specific antibody-producing hybrids, clarified by centrifugaThe publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. and incubated for 1 hr at 37°C. Cytotoxicity was scored as previously described (18) . After six washes in HWM, embryos were transferred to a small drop of the same medium under paraffin oil on a microscope slide and examined with a Leitz microscope equipped with fluorescent epiilumination and X50
water immersion lens. For RIA, embryos were washed six times in phosphate-buffered saline/fetal bovine serum/azide, transferred to tubes, and assayed for radioactivity in a Packard gamma counter. RIA and antibody-mediated complementdependent lysis on tissue-cultured cells were performed as previously described (23) .
RESULTS
Detection and Isolation of Antibody-Producing Hybrid Cells. Supernatant fluids from 14 separate colonies of cells proliferating in hypoxanthine/aminopterin/thymidine medium were tested in RIA on target F9 cells with 125I-labeled GAMIG as the second reagent. Supernatant from one of these colonies was found positive. This colony was propagated in vitro and cloned by limiting dilution.
Characterization of Antibody. Supernatant fluids from the parental colony and a clone were tested with mouse immunoglobulin class-specific reagents in Ouchterlony double immunodiffusion. Precipitation lines of identity were found with goat IgG anti-mouse 'y (secreted by the parental myeloma), with goat IgG anti-mouse g chain sera, and with goat IgG anti-mouse K; no activity with the anti-mouse X chain sera was found. Sodium dodecyl sulfate gel electrophoresis of reduced immunoprecipitates (using RAMu) of radiolabeled supernatants from the hybrid colony showed a Coomassie blue-stained band of 68,000 Mr, compatible with the molecular weight of mouse ,u chain. After these determinations were made, anti-mouse ,u chain-specific reagents were used in all indirect immunologic testing.
Sera and ascites fluid from hybrid tumor-bearing mice were titered on F9 teratocarcinoma target cells. In the interests of uniformity the serum from one of these mice has been used for the remainder of the work reported herein.
Reactivity of the Monoclonal Reagent on Cell Lines. In order to determine specificity of the monoclonal reagent, it was reacted on a series of mouse and human cell lines in RIA (Table  1 and These results were corroborated by absorption of the monoclonal reagent with the same cell lines. When quantitative absorption was performed with increasing numbers of cells at 1:32,000 dilution (approximately 75% of maximum binding on F9 cells) and the absorbed reagent was tested on F9 cells, the cell lines again fell into the same distinct categories (Fig. 1) . Each of the mouse teratocarcinoma stem cell lines tested absorbed the antiserum reactivity; MH was most effective (5.5 X 104 cells removed 50% of the binding activity on F9 cells) and 6- 50 Jl containing 5 X 105 cells). The cells were washed three times in phosphate-buffered saline/5% fetal bovine serum/0.02% azide and then incubated with 100 Ml of 125I-labeled RAMg diluted to give 50,000 input cpm. After an additional three washes, the cells were transferred to tubes for gamma counting. As a control, F9 was incubated with the same dilutions of normal BALB/c serum and the average cpm (400-600) was subtracted from the total cpm bound to give specific cpm. Cells that did not absorb any activity (shaded area) include K129SV, KGix-SV, B3T3SV, C57SV, KCA, OAIB, OTT6050f, PYS, LNSV, BW5147, and Tera 2f.
NG-2 was the least active (8 X 105 cells were required to remove the same amount of antiserum reactivity). With the human teratocarcinoma cell lines, 40% of the reactivity was removed by 106 Tera 1 cells, and 106 Tera 2 cells removed 20% of the binding activity on F9 cells. The binding activity of supernatant from the hybridoma was also tested after a single absorption at 1:10 dilution with 1.2 X 108 epididymal mouse sperm (data not shown), and it no longer reacted with F9 target cells. When volumes of packed cells equivalent to the packed cell volume of 106 F9 cells were used to absorb 200 ,ul of 1:32,000 diluted antisera human sperm, 129 strain mouse kidney and brain removed 80% of the binding ability of the monoclonal reagent on F9 cells while an equivalent volume of mouse spleen cells did not affect the binding.
Culture fluid from growing hybridomas and serum from hybridoma-bearing mice were titered in complement dependent lysis. The dilution of supernatant from the antibodyproducing hybrid cells necessary to lyse 50% of F9 cells was 1:50, while serum from hybrid tumor-bearing mice lysed 75% of F9 cells at 1:800,000 dilution (Table 2 ). Other embryo-derived murine teratocarcinoma cells were also lysed by this serum and complement with high efficiency. A small percentage of the Tera 1 human teratocarcinoma-derived cell lines were lysed at low dilutions of serum. The human teratocarcinoma cell line Tera 2 and control mouse and human cell lines were not lysed ( Table 2) .
Reactivity of the Monoclonal Reagent with Preimplantation Mouse Embryos. Embryos were tested with supernatant fluids from the hybridoma culture and with serum from hybrid tumor-bearing mice in RIA. No antibody was bound to unfertilized eggs, zygotes, and 2-and 4-cell stage embryos. Late 8-cell stage embryos and morulae bound antibody with increasing efficiency, and the amount of binding was decreased on blas-
tocysts. An increase in the amount of antibody bound was seen on inner cell masses, both freshly isolated and grown in culture, compared with blastocysts (Fig. 2) .
These same embryonic stages were tested in complementdependent lysis. No lysis of embryos prior to the 8-cell stage was observed. Ten to 20% of 8-cell stage embryos were lysed with antiserum dilutions up to 128,000. Morulae, blastocysts, and inner cell masses were lysed with high efficiency (Table 3) .
Similar results were obtained with embryos in indirect immunofluorescence assays; unfertilized eggs, zygotes, and 2-and 4-cell stage embryos were negative. Of the 8-cell stage embryos investigated, approximately 10% consisted of all positive blastomeres, 10-20% had some positive and some negative blas- embryos. Inner cell masses grown in vitro for up to 3 days were positive, although some negative cells were also present. Ectoderm exposed by removing the outer layer of entoderm from inner cell masses grown in vitro (25) was always completely positive (Fig. 3g) 
